{"id":"W4312157419","doi":"10.1016/j.msard.2022.104477","title":"Switching to natalizumab or fingolimod in multiple sclerosis: Comparative effectiveness and effect of pre-switch disease activity","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"NeuroRx Research (Canada); Centre intégré de santé et de services sociaux de Chaudière-Appalaches; Hôpital Notre-Dame","funders":"Sanofi Genzyme; Multiple Sclerosis Society; Alexion Pharmaceuticals; Teva Pharmaceutical Industries; Biogen; Celgene; Sanofi","keywords":"Fingolimod; Natalizumab; Medicine; Multiple sclerosis; Glatiramer acetate; Hazard ratio; Internal medicine; Confidence interval; Physical therapy; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01174629,0.0006652641,0.001536082,0.001086425,0.0002093812,0.00116681,0.0008266597,0.001157701,0.001908459],"category_scores_gemma":[0.01742696,0.000319336,0.004704198,0.0008339647,0.0008278405,0.000970342,0.0007205602,0.001262418,0.0001648625],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009371851,"about_ca_system_score_gemma":0.0005560115,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001220728,"about_ca_topic_score_gemma":0.001060419,"domain_scores_codex":[0.9902951,0.007196048,0.0007323921,0.0007673892,0.0007025884,0.0003065932],"domain_scores_gemma":[0.9850465,0.009935768,0.003089873,0.0009580035,0.0002414366,0.0007283614],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.7295396,0.004157941,0.1302096,0.002320343,0.04931507,0.000113094,0.0002630739,0.003387194,0.001071929,0.0004884225,0.0004935165,0.07864008],"study_design_scores_gemma":[0.2024822,0.241552,0.44686,0.001032318,0.08958571,0.0005933302,0.000449651,0.009001103,0.00319493,0.002182945,0.002917662,0.0001481788],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9850367,0.01297622,0.0002214832,0.0001922669,0.00008047611,0.0001575336,0.0004131613,0.000009879655,0.0009123109],"genre_scores_gemma":[0.9974235,0.00184061,0.00015969,0.00007627065,0.00007629043,0.00005227169,0.0002781722,0.000002543893,0.00009045564],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01174629,"threshold_uncertainty_score":0.06212103,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04864018171732619,"score_gpt":0.3034846335300865,"score_spread":0.2548444518127603,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}